EuroProxima Beta-Agonist
Art. No.: 5061BAG
Product info
Intended use
EuroProxima Beta-Agonistis a competitive enzyme immunoassay for quantitative analysis of β-agonists in urine (direct), urine (liquid extraction), faeces liver, kidney, bile and plasma, muscle, retina and feed.
General Information
β-Agonistic drugs are used in human healthcare for the treatment of for instance asthma. In recent years, it has been established that a number of β-agonistic drugs may have repartitioning effects in meat producing animals. The flow of nutrients is apparently shifted from adipose tissue towards muscle tissue. The result is an improved lean meat deposition and higher production efficiency. The use of β-agonists as feed additives is not permitted in the European Community. Nevertheless, there have been reported several incidences of the use of clenbuterol, salbutamol, mabuterol, mapenterol and bromobuterol in a number of European countries. Urine is still the most frequently analysed sample material, however, other sample materials are used for different reasons. In farmhouses, urine, faeces, hair and feed can be sampled. Sampling of faeces is much easier and faster than sampling of urine, and the residue levels for β-agonists are comparable. At slaughter, edible tissues (liver, kidney and muscle) can be sampled next to body fluids (plasma, urine and bile) and eye samples. Bile is one of the most suitable sample materials for the control on misuse of anabolic steroids and can be preferred for the control of both steroids and β-agonists. Plasma samples are frequently used for pharmacokinetic studies.
| Specifications | |
|---|---|
| Art. No | 5061BAG |
| Test format | Microtiter plate with 96 wells (12 strips with 8 wells each). |
| Sample preparation | For mentioned matrices fast and efficient extraction methods are included in the kit description. |
| Incubation time | 1 h 30 min |
| LOD (Detection Limit) | Urine (direct) (0.75 μg/L (ppb)), urine (liquid extraction) (0.1 μg/L), faeces liver, kidney, bile and plasma (0.25 μg/kg), muscle (0.2 μg/kg), retina (0.8 μg/kg), feed (10 μg/kg) |
| Validated matrices | Urine (direct), urine (liquid extraction), faeces liver, kidney, bile and plasma, muscle, retina and feed. |
| Detected analyte | β-agonists in urine (direct), urine (liquid extraction), faeces liver, kidney, bile and plasma, muscle, retina and feed. |
| Evaluation | Microtiter plate spectrophotometer (450 nm) |
| Files | |
|---|---|
| Instructions | English |
| MSDS | 5061BAG.zip (English) |